(Q33821279)

29 July 2017

1 reference

title

The use of sulphonylureas in the elderly (English)

1 reference

29 July 2017

Graal MB

1

1 reference

PubMed ID

10641958

29 July 2017

Wolffenbuttel BH

series ordinal

2

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

15

1 reference

29 July 2017

6

1 reference

29 July 2017

471-481

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199915060-00007

29 July 2017

0 references

cites work

The sulphonylurea receptor may be an ATP-sensitive potassium channel.

1 reference

12 December 2020

Individual sulfonylureas and serious hypoglycemia in older people.

1 reference

12 December 2020

The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

1 reference

12 December 2020

Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

12 December 2020

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Cross-sectional estimates of active life expectancy for the U.S. elderly and oldest-old populations

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Drug-induced reversal of early diabetic microangiopathy

1 reference

12 December 2020

Benefits and Risks With Glyburide and Glipizide in Elderly NIDDM Patients

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

1 reference

12 December 2020

Clinical biostatistics. XXXV. The persistent clinical failures and fallacies of the UGDP study

1 reference

12 December 2020

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

1 reference

12 December 2020

Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing

1 reference

12 December 2020

Document of care for older people with diabetes. Special Interest Group in Diabetes, British Geriatrics Society

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

Impact of dosage frequency on patient compliance.

1 reference

12 December 2020

The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.

1 reference

12 December 2020

"Settling the UGDP Controversy"?

1 reference

12 December 2020

How to measure insulin action in vivo

1 reference

12 December 2020

Diabetes mellitus in elderly patients. Is it different?

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of glyburide in young and elderly nondiabetic adults.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Comparison of different insulin regimens in elderly patients with NIDDM.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Oral antidiabetic agents. A guide to selection

1 reference

12 December 2020

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas

1 reference

12 December 2020

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics

1 reference

12 December 2020

1 reference

12 December 2020

Diabetic retinopathy in non-insulin-dependent diabetes mellitus patients: the role of gliclazide

1 reference

12 December 2020

1 reference

12 December 2020

Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).

1 reference

12 December 2020

The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients

1 reference

12 December 2020

Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues

1 reference

12 December 2020

Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study

1 reference

12 December 2020

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Glimepiride. A review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Glibenclamide vs gliclazide in type 2 diabetes of the elderly

1 reference

12 December 2020

Non-insulin dependent diabetes mellitus: defects in insulin secretion

1 reference

12 December 2020

Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study

1 reference

12 December 2020

Drug therapy: drug disposition in old age.

1 reference

12 December 2020

Problems and pitfalls of sulphonylurea therapy in older patients

1 reference

12 December 2020

Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations

1 reference

12 December 2020

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

1 reference

12 December 2020

Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.

1 reference

12 December 2020

Repaglinide--a new compound for the treatment of patients with type 2 diabetes.

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas

1 reference

12 December 2020

Preventive effect of gliclazide on experimental atherosclerosis in rabbits

1 reference

12 December 2020

Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment.

1 reference

12 December 2020

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

1 reference

12 December 2020

Excretion of tolbutamide metabolites in young and old subjects

1 reference

12 December 2020

Effects of aging on insulin secretion

1 reference

12 December 2020

Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.

1 reference

12 December 2020

Diabetes in the elderly

1 reference

12 December 2020

10.2165/00002512-199915060-00007

Identifiers

DOI

1 reference

PubMed ID

10641958

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10641958